These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1344303)

  • 1. A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats.
    Fleshner M; Watkins LR; Redd JM; Kruse CA; Bellgrau D
    Cell Transplant; 1992; 1(4):307-12. PubMed ID: 1344303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
    Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells.
    Kulprathipanja NV; Kruse CA
    J Neuroimmunol; 2004 Aug; 153(1-2):76-82. PubMed ID: 15265665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma.
    Kruse CA; Mitchell DH; Kleinschmidt-DeMasters BK; Bellgrau D; Eule JM; Parra JR; Kong Q; Lillehei KO
    J Neurooncol; 1993 Feb; 15(2):97-112. PubMed ID: 8509824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
    Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
    Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
    Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
    DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
    J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.
    Jean WC; Spellman SR; Wallenfriedman MA; Flores CT; Kurtz BP; Hall WA; Low WC
    J Neurooncol; 2004 Jan; 66(1-2):39-49. PubMed ID: 15015768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
    Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G
    Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.
    Fakhrai H; Dorigo O; Shawler DL; Lin H; Mercola D; Black KL; Royston I; Sobol RE
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2909-14. PubMed ID: 8610141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.
    Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA
    J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral administration of heat-inactivated Staphylococcus epidermidis enhances oncolysis and prolongs survival in a 9L orthotopic gliosarcoma model.
    Löhr M; Molcanyi M; Poggenborg J; Spuentrup E; Runge M; Röhn G; Härtig W; Hescheler J; Hampl JA
    Cell Physiol Biochem; 2013; 31(4-5):614-24. PubMed ID: 23652608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy.
    Liu Y; Ng K; Lillehei KO
    Neurosurg Focus; 2000 Dec; 9(6):e3. PubMed ID: 16817686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells.
    Smilowitz HM; Joel DD; Slatkin DN; Micca PL; Nawrocky MM; Youngs K; Tu W; Coderre JA
    J Neurooncol; 2000; 46(3):193-203. PubMed ID: 10902851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors].
    Xiao ZY; Chen XJ; Yang Y; Xu RX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):661-6. PubMed ID: 26284406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.
    Liau LM; Jensen ER; Kremen TJ; Odesa SK; Sykes SN; Soung MC; Miller JF; Bronstein JM
    Cancer Res; 2002 Apr; 62(8):2287-93. PubMed ID: 11956085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy of the rat 9L gliosarcoma: evaluation of the effects of shark cartilage.
    Morris GM; Coderre JA; Micca PL; Lombardo DT; Hopewell JW
    Br J Radiol; 2000 Apr; 73(868):429-34. PubMed ID: 10844870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
    Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
    Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.